BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2015 6:44:00 PM | Browse: 1248 | Download: 2565
 |
Received |
|
2015-05-08 08:10 |
 |
Peer-Review Started |
|
2015-05-09 19:51 |
 |
To Make the First Decision |
|
2015-06-03 14:55 |
 |
Return for Revision |
|
2015-06-09 11:30 |
 |
Revised |
|
2015-06-12 06:19 |
 |
Second Decision |
|
2015-06-29 08:21 |
 |
Accepted by Journal Editor-in-Chief |
|
2015-06-30 20:28 |
 |
Accepted by Executive Editor-in-Chief |
|
2015-07-08 15:33 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-09-17 15:37 |
 |
Publish the Manuscript Online |
|
2015-09-24 18:44 |
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Hematology |
Manuscript Type |
Retrospective Study |
Article Title |
Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study
|
Manuscript Source |
Invited Manuscript |
All Author List |
Francesco Marchesi, Fulvia Pimpinelli, Svitlana Gumenyuk, Daniela Renzi, Francesca Palombi, Francesco Pisani, Atelda Romano, Antonio Spadea, Elena Papa, Marco Canfora, Fabrizio Ensoli and Andrea Mengarelli |
Funding Agency and Grant Number |
|
Corresponding Author |
Francesco Marchesi, MD, Hematology and Stem Cell Transplantation Unit, Regina Elena National Cancer Institute, Via E. Chianesi 53, 00144 Rome, Italy. marchesi.francesco@tiscali.it |
Key Words |
Cytomegalovirus; Autologous hematopoietic stem cell transplantation; Lymphoma; Myeloma; HBcIgG seropositivity; Transplant-related mortality |
Core Tip |
Data about cytomegalovirus (CMV) reactivation in autologous hematopoietic stem cell transplantation (ASCT) are limited. We performed a retrospective observational study on 327 autografts consecutively performed for lymphoma (n = 126) or myeloma (n = 201) patients in our Institution. Aim of the study was to determine the incidence of and the risk factors for CMV symptomatic infection and/or end-organ disease, defined according to published recommendations, and the impact on Transplant-Related Mortality. Our data show that a symptomatic CMV infection can occur in about 11% of adult patients with lymphoma or myeloma undergoing ASCT. Most of cases of CMV reactivation are easily manageable but it can be a potentially life-threatening complication. As for risk factors, a pre-transplant HBcIgG seropositivity and a diagnosis of T-cell non-Hodgkin’s lymphoma should be considered as independent risk factors for CMV reactivation after ASCT. |
Publish Date |
2015-09-24 18:44 |
Citation |
Marchesi F, Pimpinelli F, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Ensoli F, Mengarelli A. Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study. World J Transplant 2015; 5(3): 129-136 |
URL |
http://www.wjgnet.com/2220-3230/full/v5/i3/129.htm |
DOI |
http://dx.doi.org/10.5500/wjt.v5.i3.129 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345